[Microbial secondary metabolites as inhibitors of pharmaceutically important transferases and oxidoreductases].
Microorganisms are known for their production of an enormous variety of biologically active secondary metabolites including antibiotics, immunosuppressants and anticancer agents. These compounds have many important biological activities used in the clinical practice in drug treatment of cancer, inflammatory, autoimmune diseases and metabolic disorders. The science and medicine research have been yielded hundreds items of useful knowledge in the therapy of many serious human diseases caused by pathophysiological mechanisms of enzymes. Many substances were discovered already in the last century, but the research of their potential and various modifications improving their prospects of therapeutic use still continues. The new knowledge about mechanisms of the action and enzyme inhibitors in the field of enzymology gives space in drug discovery and development of safer and more effective pharmacotherapy.
Slovenska Technicka Univerzita, Bratislava, Slovenska Republika. eva.buchtova@gmail.com
Buchtová
B
Eva
Sturdíková
S
Mária
D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D001419:Bacteria / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D010088:Oxidoreductases / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D014166:Transferases / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D010088:Oxidoreductases; D014166:Transferases